|
|
|
Volumn 273, Issue 7327, 2004, Pages 793-794
|
|
What role will dendrimer-based drug technology have in the future?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINE;
CD4 ANTIGEN;
DENDRIMER;
GADOLINIUM;
GLYCOPROTEIN GP 120;
NANOPARTICLE;
POLYLYSINE;
PROPRANOLOL;
VIVAGEL;
ARTICLE;
AUSTRALIA;
CHEMICAL STRUCTURE;
CHLAMYDIA;
CHLAMYDIASIS;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG INDUSTRY;
DRUG PROTEIN BINDING;
DRUG RESEARCH;
DRUG SAFETY;
GENE THERAPY;
GENE VECTOR;
GENITAL HERPES;
HEPATITIS B;
HEPATITIS B VIRUS;
HERPES VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYDROPHILICITY;
HYDROPHOBICITY;
IN VITRO STUDY;
INTERNET;
NANOTECHNOLOGY;
NONHUMAN;
PARTICLE SIZE;
PRIMATE;
SIMIAN IMMUNODEFICIENCY VIRUS;
TRANSPORT KINETICS;
VERRUCA VULGARIS;
VIRUS TRANSMISSION;
WART VIRUS;
|
|
EID: 10244236675
PISSN: 00316873
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (3)
|
